Intercoastal Medical Group

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease8 trials
• Mild cognitive impairment2 trials
• Obesity2 trials
• Stroke2 trials
• Coronary artery disease1 trial
• Heart failure1 trial
• High blood pressure1 trial
• Pulmonary arterial hypertension1 trial
• Schizophrenia1 trial

Phase

• Phase 38 trials
• Phase 24 trials

Status

• Completed6 trials
• Recruiting3 trials
• Active, not recruiting2 trials
• Not yet recruiting1 trial
• Suspended1 trial

Lead sponsor

• Novo Nordisk A/S3 trials
• Amgen2 trials
• Eli Lilly and Company2 trials
• Bristol-Myers Squibb1 trial
• Green Valley (Shanghai) Pharmaceuticals Co., Ltd.1 trial
• and 4 more

Running trials

• Recruiting

  A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  NCT07567001· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Recruiting

  A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  NCT06976203· Phase 3· Bristol-Myers Squibb· Source

  Contact: Mauricio Concha, Site 0082

• Recruiting

  DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  NCT06388421· United Therapeutics· Source

  Contact: Ryan Dunn, MD

• Recruiting

  A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  NCT06540833· Phase 2· Intra-Cellular Therapies, Inc.· Source

• Active, not recruiting

  A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  NCT04437511· Phase 3· Eli Lilly and Company· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting
• Heart failure1 recruiting
• High blood pressure1 recruiting
• Obesity1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Schizophrenia1 recruiting

Closed trials

• Completed

  A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease

  NCT06538116· Phase 2· Eli Lilly and Company· Source

• Completed

  A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

  NCT05953480· Phase 2· Shionogi· Source

• Completed

  A Study of Seltorexant in Participants With Probable Alzheimer's Disease

  NCT05307692· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

  NCT04777396· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

  NCT04777409· Phase 3· Novo Nordisk A/S· Source

• Completed

  Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke

  NCT03872401· Phase 3· Amgen· Source